Inflammation and Immune Reactions in the Fetus as a Response to COVID-19 in the Mother

NR Gashimova, LL Pankratyeva, VO Bitsadze… - Journal of Clinical …, 2023 - mdpi.com
Background: Contracting COVID-19 during pregnancy can harm both the mother and the
unborn child. Pregnant women are highly likely to develop respiratory viral infection …

Therapeutic roles of CAR T cells in infectious diseases: Clinical lessons learnt from cancer

M Mohammadi, M Akhoundi, S Malih… - Reviews in Medical …, 2022 - Wiley Online Library
Cancer immunotherapy has made improvements due to the advances in chimaeric antigen
receptor (CAR) T cell development, offering a promising treatment option for patients who …

Resistance training before, during, and after COVID-19 infection: What have we learned so far?

P Gentil, CAB de Lira, CA Vieira… - International journal of …, 2022 - mdpi.com
At the end of 2019, a severe acute respiratory syndrome caused by SARS-CoV-2 started a
pandemic, leading to millions of deaths and many important political and social changes …

Clinical features, diagnosis and treatment of COVID-19

J Ali, Q Ali, MM Hafeez, A Malik - Biological and Clinical Sciences …, 2020 - bcsrj.com
The COVID-19 has affected worldwide population at every level from advance to under
developed countries and also majorly affected clinical microbiology labs. This critique …

Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm

A Rabiu Abubakar, R Ahmad, AB Rowaiye, S Rahman… - Life, 2022 - mdpi.com
COVID-19-infected patients require an intact immune system to suppress viral replication
and prevent complications. However, the complications of SARS-CoV-2 infection that led to …

Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells

A Besaratinia, AW Caliri, S Tommasi - DNA repair, 2021 - Elsevier
Since the early stages of the pandemic, hydroxychloroquine (HCQ), a widely used drug with
good safety profile in clinic, has come to the forefront of research on drug repurposing for …

Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19

J Zepeda-Cervantes, D Martínez-Flores… - Viruses, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the
current pandemic affecting almost all countries in the world. SARS-CoV-2 is the agent …

Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury

R Vaka, S Khan, B Ye, Y Risha, S Parent… - Stem Cell Research & …, 2022 - Springer
Background Although 90% of infections with the novel coronavirus 2 (COVID-19) are mild,
many patients progress to acute respiratory distress syndrome (ARDS) which carries a high …

[PDF][PDF] SARS-CoV-2 Nsp15 suppresses type I interferon production by inhibiting IRF3 phosphorylation and nuclear translocation

D Zhang, L Ji, X Chen, Y He, Y Sun, L Ji, T Zhang… - Iscience, 2023 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes 2019
coronavirus disease (COVID-19), poses a significant threat to global public health security …

[HTML][HTML] COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes

ZNA Said, SA El Habashy, S Zaky - World Journal of …, 2023 - ncbi.nlm.nih.gov
The risk of liver injury in patients with coronavirus disease 2019 (COVID-19) infection is
quite evident. Furthermore, liver function test abnormalities are still detected in COVID-19 …